Cardiovascular manifestations of phaeochromocytoma
- PMID: 21826022
- DOI: 10.1097/HJH.0b013e32834a4ce9
Cardiovascular manifestations of phaeochromocytoma
Abstract
Clinical expression of phaeochromocytoma may involve numerous cardiovascular manifestations, but usually presents as sustained or paroxysmal hypertension associated with other signs and symptoms of catecholamine excess. Most of the life-threatening cardiovascular manifestations of phaeochromocytoma, such as hypertensive emergencies, result from a rapid and massive release of catecholamines from the tumour. More rarely, patients with phaeochromocytoma present with low blood pressure or even shock that may then precede multisystem crisis. Sinus tachycardia, with palpitations as the presenting symptom, is the most prevalent abnormality of cardiac rhythm in phaeochromocytoma, but tumours can also be associated with more serious ventricular arrhythmias or conduction disturbances. Reversible dilated or hypertrophic cardiomyopathy are well established cardiac manifestations of phaeochromocytoma, with more recent attention to an increasing number of cases with Takotsubo cardiomyopathy. This review provides an update on the cause, clinical presentation and treatment of the cardiovascular manifestations of phaeochromocytoma. As the cardiovascular complications of phaeochromocytoma can be life-threatening, all patients who present with manifestations that even remotely suggest excessive catecholamine secretion should be screened for the disease.
Similar articles
-
Normotension, ventricular tachycardia and palpitation: an unusual presentation of phaeochromocytoma.Br J Clin Pract. 1989 Apr;43(4):163-4. Br J Clin Pract. 1989. PMID: 2590629
-
A rare cause of cardiogenic shock: catecholamine cardiomyopathy of pheochromocytoma.Ital Heart J. 2002 Jun;3(6):375-8. Ital Heart J. 2002. PMID: 12116803
-
[Myocardial damage and pheochromocytoma. Description of 2 cases and review of the literature].Minerva Med. 1990 Oct;81(10):741-7. Minerva Med. 1990. PMID: 2234473 Review. Italian.
-
[Pheochromocytoma--rare and often undiagnosed condition].Lakartidningen. 2002 Mar 19;99(14):1585-9. Lakartidningen. 2002. PMID: 12025214 Review. Swedish.
-
High incidence of cardiovascular complications in pheochromocytoma.Horm Metab Res. 2012 May;44(5):379-84. doi: 10.1055/s-0032-1306294. Epub 2012 Apr 19. Horm Metab Res. 2012. PMID: 22517556
Cited by
-
Long-term outcomes and prognostic factors of metastatic or recurrent pheochromocytoma and paraganglioma: a 20-year review in a single institution.Sci Rep. 2024 Nov 2;14(1):26456. doi: 10.1038/s41598-024-75354-9. Sci Rep. 2024. PMID: 39488586 Free PMC article.
-
Cardiogenic shock in phaeochromocytoma multisystem crisis: a case report.Eur Heart J Case Rep. 2024 Sep 9;8(9):ytae463. doi: 10.1093/ehjcr/ytae463. eCollection 2024 Sep. Eur Heart J Case Rep. 2024. PMID: 39319178 Free PMC article.
-
Prevention and management of hypertensive crises in children with pheochromocytoma and paraganglioma.Front Endocrinol (Lausanne). 2024 Aug 20;15:1460320. doi: 10.3389/fendo.2024.1460320. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39229379 Free PMC article. Review.
-
Hypertension in a Patient With Polycystic Kidney Disease Complicated by Concomitant Pheochromocytoma.AACE Clin Case Rep. 2024 Apr 13;10(4):136-139. doi: 10.1016/j.aace.2024.04.001. eCollection 2024 Jul-Aug. AACE Clin Case Rep. 2024. PMID: 39100633 Free PMC article.
-
Impact of Coronary Microvascular Dysfunction in Takotsubo Syndrome: Cause, Consequence or Both?Rev Cardiovasc Med. 2024 May 11;25(5):163. doi: 10.31083/j.rcm2505163. eCollection 2024 May. Rev Cardiovasc Med. 2024. PMID: 39076465 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
